An Ultrasensitive New DNA Microarray Chip Provides Gene Expression Profiles for Preoperative Esophageal Cancer Biopsies without RNA Amplification

Objectives: Gene expression profiling using pretreatment biopsies has been limited due to their small sample sizes. This study evaluated the usefulness of an ultrasensitive new DNA microarray chip, which has a unique array structure, for the clinical diagnosis of esophageal cancer using preoperative biopsies. Methods: Paired cancer and normal esophageal epithelial tissues from 56 patients who underwent esophagectomy and from 48 patients who underwent preoperative endoscopy were studied. Among 2 feature gene sets selected by a reference DNA chip discriminating malignant status of samples, 20 feature genes were selected for the development of the new DNA chip. The new DNA chip was hybridized with 0.1 µg of total RNA per slide without RNA amplification. Results: Twenty feature genes, including RRM-2 and XRCC-3, for the new DNA chip could discriminate cancer from noncancer at a 95.2% rate of accuracy in 42 biopsies (sensitivity 95.7%, specificity 94.7%). A receiver operating characteristic (ROC) curve analysis showed that the area under ROC curve for the prediction was 0.966. Conclusions: The gene expression profiles from the preoperative biopsies could diagnose esophageal cancer accurately, using the ultrasensitive DNA chip without RNA amplification. This new DNA chip technology might contribute further to the development of customized therapeutic strategies for various cancer patients.

[1]  Daniel W Lin,et al.  Influence of surgical manipulation on prostate gene expression: implications for molecular correlates of treatment effects and disease prognosis. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  G. Tsujimoto,et al.  Ultrasensitive DNA chip: gene expression profile analysis without RNA amplification. , 2006, Journal of Biochemistry (Tokyo).

[3]  Jeffrey T. Chang,et al.  Oncogenic pathway signatures in human cancers as a guide to targeted therapies , 2006, Nature.

[4]  T. Yeatman,et al.  Classification of human tumors using gene expression profiles obtained after microarray analysis of fine‐needle aspiration biopsy samples , 2005, Cancer.

[5]  Yutaka Shimada,et al.  Prediction of Lymph Node Metastasis with Use of Artificial Neural Networks Based on Gene Expression Profiles in Esophageal Squamous Cell Carcinoma , 2004, Annals of Surgical Oncology.

[6]  A. Borkowski,et al.  Esophagin and proliferating cell nuclear antigen (PCNA) are biomarkers of human esophageal neoplastic progression , 2004, International journal of cancer.

[7]  Edward R. Dougherty,et al.  Is cross-validation valid for small-sample microarray classification? , 2004, Bioinform..

[8]  Andrej-Nikolai Spiess,et al.  Amplified RNA degradation in T7-amplification methods results in biased microarray hybridizations , 2003, BMC Genomics.

[9]  D. M. Parkin,et al.  Corrigendum to “Cancer burden in the year 2000. The global picture” [European Journal of Cancer,37(Suppl. 8) (2001) S4–S66] , 2003 .

[10]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[11]  Neil Winegarden,et al.  Representation is faithfully preserved in global cDNA amplified exponentially from sub-picogram quantities of mRNA , 2002, Nature Biotechnology.

[12]  Yusuke Nakamura,et al.  Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas , 2002, Oncogene.

[13]  László G Puskás,et al.  RNA amplification results in reproducible microarray data with slight ratio bias. , 2002, BioTechniques.

[14]  Suna Wang,et al.  Activation of the esophagin promoter during esophageal epithelial cell differentiation. , 2002, Genomics.

[15]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[16]  P. D. De Leyn,et al.  Cancer of the esophagus and gastro-esophageal junction: potentially curative therapies. , 2001, Surgical oncology.

[17]  F. Bray,et al.  Cancer burden in the year 2000. The global picture. , 2001, European journal of cancer.

[18]  F. Sato,et al.  Gene expression profiling in human esophageal cancers using cDNA microarray. , 2001, Biochemical and biophysical research communications.

[19]  D. Miller,et al.  Ivor Lewis esophagogastrectomy for esophageal cancer. , 2001, The Annals of thoracic surgery.

[20]  J. Abraham,et al.  Esophagin cDNA cloning and characterization: a tissue-specific member of the small proline-rich protein family that is not expressed in esophageal tumors. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[21]  J. Mesirov,et al.  An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis , 2005, Nature Genetics.

[22]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.